Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare CancersPeter Horak, Klaus Schulze‐Osthoff, Christoph E. Heilig et al.|Cancer Discovery|2021Cited by 282
TUSC3 Loss Alters the ER Stress Response and Accelerates Prostate Cancer Growth in vivoPeter Horak, Michael Krainer|Scientific Reports|2014Cited by 61
CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebaseKilannin Krysiak, Zachary L. Skidmore, Arpad Danos et al.|Nucleic Acids Research|2022Cited by 46
Trailblazing precision medicine in Europe: A joint view by Genomic Medicine Sweden and the Centers for Personalized Medicine, ZPM, in GermanyAlbrecht Stenzinger, Verena I. Gaidzik, Anders Edsjö et al.|Seminars in Cancer Biology|2021Cited by 38
Translational and clinical comparison of whole genome and transcriptome to panel sequencing in precision oncologyIrina Kerle, Hanno Glimm, Thomas Groß et al.|npj Precision Oncology|2025Cited by 17